{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:35:52Z","timestamp":1751373352347,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Istituto Superiore di Sanit\u00e0, Italy","award":["Conv. ONC\/1E"],"award-info":[{"award-number":["Conv. ONC\/1E"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3334-1","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T12:32:01Z","timestamp":1495715521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0471-7127","authenticated-orcid":false,"given":"Laura","family":"Zanotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Romani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Tassone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Todeschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata Alessandra","family":"Tassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Bandiera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Damia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Ardighieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Calza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Marchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Beltrame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germana","family":"Tognon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"D\u2019Incalci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Pecorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Odicino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Ravaggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana","family":"Bignotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,25]]},"reference":[{"key":"3334_CR1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","volume":"34","author":"RJ Kurman","year":"2010","unstructured":"Kurman RJ, leM S. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010;34:433\u201343.","journal-title":"Am J Surg Pathol"},{"key":"3334_CR2","doi-asserted-by":"crossref","unstructured":"Bagnoli M, Beretta GL, Gatti L, Pilotti S, Alberti P, Tarantino E, et al. Clinicopathological impact of ABCC1\/MRP1 and ABCC4\/MRP4 in epithelial ovarian carcinoma. Biomed Res Int. 2013;143202","DOI":"10.1155\/2013\/143202"},{"key":"3334_CR3","doi-asserted-by":"crossref","unstructured":"Dyall S, Gayther SA, Dafou D. Cancer stem cells and epithelial ovarian cancer. J Oncol. 2010;105269","DOI":"10.1155\/2010\/105269"},{"key":"3334_CR4","doi-asserted-by":"crossref","first-page":"10158","DOI":"10.1073\/pnas.0703478104","volume":"104","author":"P Dalerba","year":"2007","unstructured":"Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A. 2007;104:10158\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3334_CR5","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730\u20137.","journal-title":"Nat Med"},{"key":"3334_CR6","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1158\/0008-5472.CAN-05-0626","volume":"65","author":"D Ponti","year":"2005","unstructured":"Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem\/progenitor cell properties. Cancer Res. 2005;65:5506\u201311.","journal-title":"Cancer Res"},{"key":"3334_CR7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature05384","volume":"445","author":"L Ricci-Vitiani","year":"2007","unstructured":"Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007;445:111\u20135.","journal-title":"Nature"},{"key":"3334_CR8","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1158\/0008-5472.CAN-04-3931","volume":"65","author":"SA Bapat","year":"2005","unstructured":"Bapat SA, Mali AM, Koppikar CB, Kurrey NK. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res. 2005;65:3025\u20139.","journal-title":"Cancer Res"},{"key":"3334_CR9","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.4161\/cc.20308","volume":"11","author":"F Ricci","year":"2012","unstructured":"Ricci F, Bernasconi S, Perego P, Ganzinelli M, Russo G, Bono F, et al. Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype. Cell Cycle. 2012;11:1966\u201376.","journal-title":"Cell Cycle"},{"key":"3334_CR10","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/j.humpath.2013.05.001","volume":"44","author":"X Chen","year":"2013","unstructured":"Chen X, Zhang J, Zhang Z, Li H, Cheng W, Liu J. Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma. Hum Pathol. 2013;44:2373\u201384.","journal-title":"Hum Pathol"},{"key":"3334_CR11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11010-011-1178-6","volume":"363","author":"L Wang","year":"2012","unstructured":"Wang L, Mezencev R, Bowen NJ, Matyunina LV, McDonald JF. Isolation and characterization of stem-like cells from a human ovarian cancer cell line. Mol Cell Biochem. 2012;363:257\u201368.","journal-title":"Mol Cell Biochem"},{"key":"3334_CR12","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1007\/s00018-010-0420-9","volume":"67","author":"MF Shi","year":"2010","unstructured":"Shi MF, Jiao J, Lu WG, Ye F, Ma D, Dong QG, et al. Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line. Cell Mol Life Sci. 2010;67:3915\u201325.","journal-title":"Cell Mol Life Sci"},{"key":"3334_CR13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/ijc.20408","volume":"112","author":"AD Santin","year":"2004","unstructured":"Santin AD, Zhan F, Bellone S, Palmieri M, Cane S, Bignotti E, et al. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy. Int J Cancer. 2004;112:14\u201325.","journal-title":"Int J Cancer"},{"key":"3334_CR14","first-page":"7","volume":"Suppl 12","author":"N Colombo","year":"2014","unstructured":"Colombo N. Optimising the treatment of the partially platinum-sensitive relapsed ovarian cancer patient. EJC. 2014;Suppl 12:7\u201312.","journal-title":"EJC"},{"key":"3334_CR15","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"3334_CR16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the False discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc. 1995;57:289\u2013300.","journal-title":"J R Statist Soc"},{"key":"3334_CR17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ygyno.2006.03.056","volume":"103","author":"E Bignotti","year":"2006","unstructured":"Bignotti E, Tassi RA, Calza S, Ravaggi A, Romani C, Rossi E, et al. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. Gynecol Oncol. 2006;103:405\u201316.","journal-title":"Gynecol Oncol"},{"key":"3334_CR18","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","volume":"68","author":"S Zhang","year":"2008","unstructured":"Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 2008;68:4311\u201320.","journal-title":"Cancer Res"},{"key":"3334_CR19","doi-asserted-by":"crossref","first-page":"8944","DOI":"10.1158\/0008-5472.CAN-05-0931","volume":"65","author":"M Locke","year":"2005","unstructured":"Locke M, Heywood M, Fawell S, Mackenzie IC. Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res. 2005;65:8944\u201350.","journal-title":"Cancer Res"},{"key":"3334_CR20","first-page":"13","volume":"11","author":"B Ffrench","year":"2014","unstructured":"Ffrench B, Gasch C, John J, O\u2019Leary JJ, Gallagher MF. Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention. Mol Cancer. 2014;11:13\u2013262.","journal-title":"Mol Cancer"},{"key":"3334_CR21","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1002\/stem.236","volume":"27","author":"MD Curley","year":"2009","unstructured":"Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR, Friel AM, et al. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells. 2009;27:2875\u201383.","journal-title":"Stem Cells"},{"issue":"2","key":"3334_CR22","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.yexmp.2011.06.005","volume":"91","author":"L Luo","year":"2011","unstructured":"Luo L, Zeng J, Liang B, Zhao Z, Sun L, Cao D, et al. Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome. Exp Mol Pathol. 2011;91(2):596\u2013602.","journal-title":"Exp Mol Pathol"},{"key":"3334_CR23","first-page":"1121","volume":"27","author":"VC Mak","year":"2012","unstructured":"Mak VC, Siu MK, Wong OG, Chan KK, Ngan HY, Cheung AN. Dysregulated stemness-related genes in gynecological malignancies. Histol Histopathol. 2012;27:1121\u201330.","journal-title":"Histol Histopathol"},{"key":"3334_CR24","first-page":"1249","volume":"6","author":"I Espinoza","year":"2013","unstructured":"Espinoza I, Pochampally R, Xing F, Watabe K, Miele L. Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition. Onco Targets Ther. 2013;6:1249\u201359.","journal-title":"Onco Targets Ther"},{"key":"3334_CR25","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1158\/1535-7163.MCT-10-0563","volume":"9","author":"CN Landen Jr","year":"2010","unstructured":"Landen CN Jr, Goodman B, Katre AA, Steg AD, Nick AM, Stone RL, et al. Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer. Mol Cancer Ther. 2010;9:3186\u201399.","journal-title":"Mol Cancer Ther"},{"key":"3334_CR26","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704\u201315.","journal-title":"Cell"},{"key":"3334_CR27","first-page":"1271","volume":"31","author":"H Yoshida","year":"2011","unstructured":"Yoshida H, Sumi T, Zhi X, Yasui T, Honda K, Ishiko O. Claudin-4: a potential therapeutic target in chemotherapy-resistant ovarian cancer. Anticancer Res. 2011;31:1271\u20137.","journal-title":"Anticancer Res"},{"key":"3334_CR28","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3390\/ijms12021334","volume":"12","author":"KL Boylan","year":"2011","unstructured":"Boylan KL, Misemer B, De Rycke MS, Andersen JD, Harrington KM, Kalloger SE, et al. Claudin 4 is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation. Int J Mol Sci. 2011;12:1334\u201358.","journal-title":"Int J Mol Sci"},{"key":"3334_CR29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-1-59745-280-9_17","volume":"568","author":"VS Donnenberg","year":"2009","unstructured":"Donnenberg VS, Meyer EM, Donnenberg AD. Measurement of multiple drug resistance transporter activity in putative cancer stem\/progenitor cells. Methods Mol Biol. 2009;568:261\u201379.","journal-title":"Methods Mol Biol"},{"key":"3334_CR30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/CBI20100347","volume":"35","author":"J Dou","year":"2011","unstructured":"Dou J, Jiang C, Wang J, Zhang X, Zhao F, Hu W, et al. Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line. Cell Biol Int. 2011;35:227\u201334.","journal-title":"Cell Biol Int"},{"key":"3334_CR31","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.biocel.2004.11.004","volume":"37","author":"F Staud","year":"2005","unstructured":"Staud F, Pavek P. Breast cancer resistance protein (BCRP\/ABCG2). Int J Biochem Cell Biol. 2005;37:720\u20135.","journal-title":"Int J Biochem Cell Biol"},{"key":"3334_CR32","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1242\/jcs.114.22.3957","volume":"114","author":"MA Alonso","year":"2001","unstructured":"Alonso MA, Mill\u00e1n J. The role of lipid rafts in signalling and membrane trafficking in T lymphocytes. J Cell Sci. 2001;114:3957\u201365.","journal-title":"J Cell Sci"},{"key":"3334_CR33","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1038\/sj.onc.1206378","volume":"22","author":"K Mimori","year":"2003","unstructured":"Mimori K, Shiraishi T, Mashino K, Sonoda H, Yamashita K, Yoshinaga K, et al. MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway. Oncogene. 2003;22:3463\u201371.","journal-title":"Oncogene"},{"key":"3334_CR34","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3892\/ol.2015.3355","volume":"10","author":"R Ma","year":"2015","unstructured":"Ma R, Xu YE, Wang M, Peng W. Suppression of MAL gene expression is associated with colorectal cancer metastasis. Oncol Lett. 2015;10:957\u201361.","journal-title":"Oncol Lett"},{"key":"3334_CR35","first-page":"344","volume":"104","author":"J Kurashige","year":"2013","unstructured":"Kurashige J, Sawada G, Takahashi Y, Eguchi H, Sudo T, Ikegami T, et al. Suppression of MAL gene expression in gastric cancer correlates with metastasis and mortality. Fukuoka Igaku Zasshi. 2013;104:344\u20139.","journal-title":"Fukuoka Igaku Zasshi"},{"key":"3334_CR36","first-page":"925","volume":"19","author":"M Marazuela","year":"2004","unstructured":"Marazuela M, Alonso MA. Expression of MAL and MAL2, two elements of the protein machinery for raft-mediated transport, in normal and neoplastic human tissue. Histol Histopathol. 2004;19:925\u201333.","journal-title":"Histol Histopathol"},{"key":"3334_CR37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1158\/1541-7786.MCR-08-0314","volume":"7","author":"HN Horne","year":"2009","unstructured":"Horne HN, Lee PS, Murphy SK, Alonso MA, Olson JA Jr, Marks JR. Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy. Mol Cancer Res. 2009;7:199\u2013209.","journal-title":"Mol Cancer Res"},{"key":"3334_CR38","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1053\/j.gastro.2006.06.006","volume":"131","author":"Y Mori","year":"2006","unstructured":"Mori Y, Cai K, Cheng Y, Wang S, Paun B, Hamilton JP, et al. A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. Gastroenterology. 2006;131:797\u2013808.","journal-title":"Gastroenterology"},{"key":"3334_CR39","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0002-9440(10)64459-8","volume":"161","author":"L Tracey","year":"2002","unstructured":"Tracey L, Villuendas R, Ortiz P, Dopazo A, Spiteri I, Lombardia L, et al. Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. Am J Pathol. 2002;161:1825\u201337.","journal-title":"Am J Pathol"},{"key":"3334_CR40","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1309\/98KLHRDAM5CMDHE2","volume":"125","author":"ED Hsi","year":"2006","unstructured":"Hsi ED, Sup SJ, Alemany C, Tso E, Skacel M, Elson P, et al. MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis. Am J Clin Pathol. 2006;125:776\u201382.","journal-title":"Am J Clin Pathol"},{"key":"3334_CR41","first-page":"4722","volume":"62","author":"DR Schwartz","year":"2002","unstructured":"Schwartz DR, Kardia SL, Shedden KA, Kuick R, Michailidis G, Taylor JM, et al. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res. 2002;62:4722\u20139.","journal-title":"Cancer Res"},{"key":"3334_CR42","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1158\/1078-0432.CCR-08-2430","volume":"15","author":"A Berchuck","year":"2009","unstructured":"Berchuck A, Iversen ES, Luo J, Clarke JP, Horne H, Levine DA, et al. Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome. Clin Cancer Res. 2009;15:2448\u201355.","journal-title":"Clin Cancer Res"},{"key":"3334_CR43","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/ijc.24797","volume":"126","author":"PS Lee","year":"2010","unstructured":"Lee PS, Teaberry VS, Bland AE, Huang Z, Whitaker RS, Baba T, et al. Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer. Int J Cancer. 2010;126:1378\u201389.","journal-title":"Int J Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3334-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T10:11:45Z","timestamp":1719223905000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3334-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,25]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3334"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3334-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2017,5,25]]},"article-number":"366"}}